Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Gross Profit (Quarterly): 42.91M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 42.91M |
| December 31, 2023 | 46.51M |
| September 30, 2023 | 42.03M |
| June 30, 2023 | 38.13M |
| March 31, 2023 | 32.96M |
| December 31, 2022 | 33.10M |
| September 30, 2022 | 32.63M |
| June 30, 2022 | 30.70M |
| March 31, 2022 | 28.84M |
| December 31, 2021 | 23.68M |
| Date | Value |
|---|---|
| September 30, 2021 | 22.30M |
| June 30, 2021 | 22.30M |
| March 31, 2021 | 24.93M |
| December 31, 2020 | 19.36M |
| September 30, 2020 | 15.36M |
| June 30, 2020 | 7.082M |
| March 31, 2020 | 0.062M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 25.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
46.51M
Maximum
Dec 2023
24.39M
Average
24.97M
Median
Gross Profit (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 8.933B |
| Dynavax Technologies Corp | 39.82M |
| Gilead Sciences Inc | 5.134B |
| Esperion Therapeutics Inc | 127.66M |
| SINTX Technologies Inc | 0.086M |